cagrilintide phase 2 produced 10.8 percent body weight loss in 26 weeks in a trial. Without touching the GLP-1 pathway. Different mechanism, different lever. Cagrilintide is a long-acting amylin analog. Amylin is Updates in Medicine | CagriSema
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)






